Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases.

Publication Type:
Journal Article
Citation:
Biomark Insights, 2018, 13 pp. 1177271918785130 - ?
Issue Date:
2018
Full metadata record
Files in This Item:
Filename Description Size
1177271918785130.pdfPublished Version305.42 kB
Adobe PDF
Cardiovascular disease (CVD) is the leading cause of death in the world and our approach to the control and management of CVD mortality is limited. Nattokinase (NK), the most active ingredient of natto, possesses a variety of favourable cardiovascular effects and the consumption of Natto has been linked to a reduction in CVD mortality. Recent research has demonstrated that NK has potent fibrinolytic activity, antihypertensive, anti-atherosclerotic, and lipid-lowering, antiplatelet, and neuroprotective effects. This review covers the major pharmacologic effects of NK with a focus on its clinical relevance to CVD. It outlines the advantages of NK and the outstanding issues pertaining to NK pharmacokinetics. Available evidence suggests that NK is a unique natural compound that possesses several key cardiovascular beneficial effects for patients with CVD and is therefore an ideal drug candidate for the prevention and treatment of CVD. Nattokinase is a promising alternative in the management of CVD.
Please use this identifier to cite or link to this item: